Avidian Wealth Enterprises LLC lifted its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 0.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 15,989 shares of the company’s stock after purchasing an additional 86 shares during the quarter. Avidian Wealth Enterprises LLC’s holdings in Procter & Gamble were worth $2,769,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Itau Unibanco Holding S.A. bought a new position in shares of Procter & Gamble in the 2nd quarter valued at $28,000. Fairway Wealth LLC acquired a new position in Procter & Gamble during the second quarter worth about $29,000. Ruedi Wealth Management Inc. boosted its stake in shares of Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares in the last quarter. POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at approximately $34,000. Finally, Quest Partners LLC bought a new position in Procter & Gamble in the 2nd quarter valued at approximately $36,000. Institutional investors own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
PG has been the subject of a number of research reports. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Citigroup lifted their price target on Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. DA Davidson raised their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a report on Monday, October 21st. Morgan Stanley boosted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Finally, Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a report on Monday, September 30th. Nine research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $177.00.
Insider Activity
In other news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now owns 19,341 shares in the company, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 385,771 shares of company stock valued at $65,610,975. Company insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Performance
Shares of PG stock opened at $165.79 on Wednesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The company has a market capitalization of $390.44 billion, a P/E ratio of 28.58, a PEG ratio of 3.57 and a beta of 0.42. The stock has a 50 day moving average price of $171.45 and a two-hundred day moving average price of $168.18.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s revenue was down .6% on a year-over-year basis. During the same quarter last year, the firm earned $1.83 EPS. Analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.43%. Procter & Gamble’s dividend payout ratio is currently 69.48%.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- Using the MarketBeat Dividend Yield Calculator
- AMD: The AI Disruptor – Is It Time to Follow Big Tech’s Lead?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Analysts Signal Big Upside: Top 3 Stocks to Watch Right Now
- What Makes a Stock a Good Dividend Stock?
- Bears Misjudged These 3 ETFs: Where Investors Can Find Upside
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.